On the public citation graph
An Anti-Human Epha2 Monoclonal Antibody Ea2mab-7 Shows High Sensitivity for Flow Cytometry, Western Blot, and Immunohistochemical Analyses
0 signed · 51 inferred · view as graph
Inferred edges come from two machine sources: sweeps of open repository metadata (mostly SSRN and Zenodo), and a bulk OpenAlex citation snapshot. Every row below is labelled with the one it came from. Neither is a complete citation index — absence here is not evidence of absence.
Is this your work? Sign in with ORCID and put your name on the
claims that are yours.
Reference health. See whether every reference in this work resolves to a
known work and none has been retracted — and get a dated CiteStamped
badge you can embed.
What this work says
Outgoing claims: the papers this work cites, builds on, or argues with.
inferredcites →https://doi.org/10.1002/cncr.22415openalex-extracted
EphA2 overexpression is associated with angiogenesis in ovarian cancer
inferredcites →https://doi.org/10.1002/ijc.10860openalex-extracted
EphA2 overexpression correlates with poor prognosis in esophageal squamous cell carcinoma
inferredcites →https://doi.org/10.1002/ijc.31405openalex-extracted
EphA2 receptor is a key player in the metastatic onset of Ewing sarcoma
inferredcites →https://doi.org/10.1002/ijc.32313openalex-extracted
EPHA2 blockade reverses acquired resistance to afatinib induced by EPHA2‐mediated MAPK pathway activation in gastric cancer cells and avatar mice
inferredcites →https://doi.org/10.1007/s00441-017-2646-4openalex-extracted
Cell type-specific localization of Ephs pairing with ephrin-B2 in the rat postnatal pituitary gland
inferredcites →https://doi.org/10.1007/s10549-019-05482-8openalex-extracted
Phosphorylation of EphA2 receptor and vasculogenic mimicry is an indicator of poor prognosis in invasive carcinoma of the breast
inferredcites →https://doi.org/10.1007/s13402-020-00511-xopenalex-extracted
Effect of EphA2 knockdown on melanoma metastasis depends on intrinsic ephrinA1 level
inferredcites →https://doi.org/10.1016/j.canlet.2019.02.019openalex-extracted
ProNGF increases breast tumor aggressiveness through functional association of TrkA with EphA2
inferredcites →https://doi.org/10.1016/j.ccr.2005.07.005openalex-extracted
A conditional feedback loop regulates Ras activity through EphA2
inferredcites →https://doi.org/10.1016/j.ccr.2009.04.009openalex-extracted
EphA2 Mediates Ligand-Dependent Inhibition and Ligand-Independent Promotion of Cell Migration and Invasion via a Reciprocal Regulatory Loop with Akt
inferredcites →https://doi.org/10.1016/j.omtm.2018.01.009openalex-extracted
Optimizing EphA2-CAR T Cells for the Adoptive Immunotherapy of Glioma
inferredcites →https://doi.org/10.1016/j.tranon.2017.10.009openalex-extracted
Chimeric Antigen Receptor-Modified T Cells Redirected to EphA2 for the Immunotherapy of Non-Small Cell Lung Cancer
inferredcites →https://doi.org/10.1016/j.ygyno.2004.05.019openalex-extracted
Prognostic value of EphA2 and EphrinA-1 in squamous cell cervical carcinoma
inferredcites →https://doi.org/10.1038/ncomms8679openalex-extracted
Crucial roles of RSK in cell motility by catalysing serine phosphorylation of EphA2
inferredcites →https://doi.org/10.1038/nrc2806openalex-extracted
Eph receptors and ephrins in cancer: bidirectional signalling and beyond
inferredcites →https://doi.org/10.1038/nrm1662openalex-extracted
Eph receptor signalling casts a wide net on cell behaviour
inferredcites →https://doi.org/10.1038/s41467-021-26839-yopenalex-extracted
Nuclear-capture of endosomes depletes nuclear G-actin to promote SRF/MRTF activation and cancer cell invasion
inferredcites →https://doi.org/10.1038/s41568-023-00634-xopenalex-extracted
Eph receptors and ephrins in cancer progression
inferredcites →https://doi.org/10.1038/s41598-024-52020-8openalex-extracted
Cooperative function of oncogenic MAPK signaling and the loss of Pten for melanoma migration through the formation of lamellipodia
inferredcites →https://doi.org/10.1089/mab.2021.0005openalex-extracted
Development of Anti-Mouse CC Chemokine Receptor 8 Monoclonal Antibodies for Flow Cytometry
inferredcites →https://doi.org/10.1089/mab.2021.0007openalex-extracted
Development of Anti-Human CC Chemokine Receptor 9 Monoclonal Antibodies for Flow Cytometry
inferredcites →https://doi.org/10.1089/mab.2021.0009openalex-extracted
Development of Anti-Mouse CC Chemokine Receptor 3 Monoclonal Antibodies for Flow Cytometry
inferredcites →https://doi.org/10.1089/mab.2021.0010openalex-extracted
Epitope Mapping of an Anti-Human Epidermal Growth Factor Receptor Monoclonal Antibody (EMab-51) Using the RIEDL Insertion for Epitope Mapping Method
inferredcites →https://doi.org/10.1089/mab.2021.0012openalex-extracted
Epitope Mapping of the Anti-CD44 Monoclonal Antibody (C 44 Mab-46) Using the REMAP Method
inferredcites →https://doi.org/10.1089/mab.2021.0014openalex-extracted
Epitope Mapping of an Antihuman EGFR Monoclonal Antibody (EMab-134) Using the REMAP Method
inferredcites →https://doi.org/10.1089/mab.2021.0023openalex-extracted
Development of a Novel Epitope Mapping System: RIEDL Insertion for Epitope Mapping Method
inferredcites →https://doi.org/10.1089/mab.2021.0069openalex-extracted
Development of an Anti-Mouse CCR8 Monoclonal Antibody (C 8 Mab-1) for Flow Cytometry and Immunocytochemistry
inferredcites →https://doi.org/10.1089/mab.2023.0015openalex-extracted
Development of an Anti-EphB4 Monoclonal Antibody for Multiple Applications Against Breast Cancers
inferredcites →https://doi.org/10.1089/mab.2023.0029openalex-extracted
Epitope Mapping of an Anti-Mouse CD39 Monoclonal Antibody Using PA Scanning and RIEDL Scanning
inferredcites →https://doi.org/10.1089/mab.2024.0004openalex-extracted
Development of a Sensitive Anti-Mouse CCR5 Monoclonal Antibody for Flow Cytometry
inferredcites →https://doi.org/10.1111/tra.12123openalex-extracted
EphA2 Signaling Following Endocytosis: Role of Tiam1
inferredcites →https://doi.org/10.1158/0008-5472.can-14-2798openalex-extracted
Proteolysis of EphA2 Converts It from a Tumor Suppressor to an Oncoprotein
inferredcites →https://doi.org/10.1158/0008-5472.can-15-0717openalex-extracted
EPHA2 Blockade Overcomes Acquired Resistance to EGFR Kinase Inhibitors in Lung Cancer
inferredcites →https://doi.org/10.1158/0008-5472.can-15-0847openalex-extracted
The Ephrin-A1/EPHA2 Signaling Axis Regulates Glutamine Metabolism in HER2-Positive Breast Cancer
inferredcites →https://doi.org/10.1158/1535-7163.mct-18-0539openalex-extracted
EPHA2 Is a Predictive Biomarker of Resistance and a Potential Therapeutic Target for Improving Antiepidermal Growth Factor Receptor Therapy in Colorectal Cancer
inferredcites →https://doi.org/10.1158/1541-7786.mcr-08-0244openalex-extracted
The EphA2 Receptor and EphrinA1 Ligand in Solid Tumors: Function and Therapeutic Targeting
inferredcites →https://doi.org/10.1186/ar2447openalex-extracted
Novel splice variants derived from the receptor tyrosine kinase superfamily are potential therapeutics for rheumatoid arthritis
inferredcites →https://doi.org/10.1186/s13045-020-00944-9openalex-extracted
Targeting EphA2 in cancer
inferredcites →https://doi.org/10.1248/bpb.b17-00446openalex-extracted
Emerging and Diverse Functions of the EphA2 Noncanonical Pathway in Cancer Progression
inferredcites →https://doi.org/10.1517/14728222.2011.538682openalex-extracted
Emerging strategies for EphA2 receptor targeting for cancer therapeutics
inferredcites →https://doi.org/10.18632/aging.205212openalex-extracted
EphA2 as a phase separation protein associated with ferroptosis and immune cell infiltration in colorectal cancer
inferredcites →https://doi.org/10.2174/156800911798073050openalex-extracted
EphA2-Dependent Molecular Targeting Therapy for Malignant Tumors
inferredcites →https://doi.org/10.21873/anticanres.12592openalex-extracted
An Agonistic Antibody to EPHA2 Exhibits Antitumor Effects on Human Melanoma Cells
inferredcites →https://doi.org/10.21873/anticanres.13834openalex-extracted
Elevated Expression of EPHA2 Is Associated With Poor Prognosis After Radical Prostatectomy in Prostate Cancer
inferredcites →https://doi.org/10.2967/jnumed.115.169839openalex-extracted
Molecular Imaging and Quantitation of EphA2 Expression in Xenograft Models with 89Zr-DS-8895a
inferredcites →https://doi.org/10.3109/08977194.2014.983225openalex-extracted
Generation and characterization of a single-chain anti-EphA2 antibody
inferredcites →https://doi.org/10.3390/antib11040075openalex-extracted
Epitope Mapping of Anti-Mouse CCR3 Monoclonal Antibodies Using Flow Cytometry
inferredcites →https://doi.org/10.3390/cancers13040700openalex-extracted
EphA2 and EGFR: Friends in Life, Partners in Crime. Can EphA2 Be a Predictive Biomarker of Response to Anti-EGFR Agents?
inferredcites →https://doi.org/10.3390/diagnostics12020366openalex-extracted
EPHA2, EPHA4, and EPHA7 Expression in Triple-Negative Breast Cancer
inferredcites →https://doi.org/10.3390/ijms25179190openalex-extracted
Anti-CD44 Variant 10 Monoclonal Antibody Exerts Antitumor Activity in Mouse Xenograft Models of Oral Squamous Cell Carcinomas
inferredcites →https://doi.org/10.3892/or.2024.8806openalex-extracted
Antitumor activities of anti‑CD44 monoclonal antibodies in mouse xenograft models of esophageal cancer
Editorial review for independent work. ICSAC — the Institute for Complexity
Science and Advanced Computing — runs a structured editorial panel for researchers
publishing outside journals, and publishes on CiteStamp rails. Submission is free
and goes through ORCID: icsacinstitute.org/submit.